Retained Earnings
The latest quarterly retained earnings is $-128.00 Million with a quarter-over-quarter change of +37.25%. Retained earnings represent the cumulative net income that has been kept by the company rather than distributed to shareholders as dividends. It's a key component of shareholders' equity.
KVUE Retained Earnings
Reported quarterly retained earnings; no daily interpolation.
Current Retained Earnings
$-128.00M
$-128.00 Million
Quarter-over-Quarter Change
+37.25%
vs. $-204.00M prior quarter
Historical Data
15
Quarters of data available
Quarterly Retained Earnings History
| Period | Retained Earnings | QoQ Change | % Change |
|---|---|---|---|
| Q1 2026 | $-128.00M | +$76.00M | +37.25% |
| Q4 2025 | $-204.00M | $-68.00M | -50.00% |
| Q3 2025 | $-136.00M | +$0 | 0.00% |
| Q2 2025 | $-136.00M | +$27.00M | +16.56% |
| Q1 2025 | $-163.00M | $-70.00M | -75.27% |
| Q4 2024 | $-93.00M | $-100.00M | -1428.57% |
| Q3 2024 | $7.00M | $-10.00M | -58.82% |
| Q2 2024 | $17.00M | $-325.00M | -95.03% |
| Q1 2024 | $342.00M | $-87.00M | -20.28% |
| Q4 2023 | $429.00M | $-56.00M | -11.55% |
| Q3 2023 | $485.00M | +$55.00M | +12.79% |
| Q2 2023 | $430.00M | +$430.00M | — |
| Q1 2023 | $0 | +$0 | — |
| Q4 2023 | $0 | +$0 | — |
| Q3 2022 | $0 | — | — |
Related Metrics
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry